Table 2. UCE measurement before and 3 days after myocardium infarction (MI).

Group	LV,d (µl)	LV,s (µl)	LV,mass (mg)	LVEF (%)	LVFS (%)	E/A
NS-b prior	55.89±12.35	6.25±1.79	60.6±8.65	88.17±7.02	58.51±8.80	1.22±0.056
after	104.40±12.78	9.96±1.11	76.0±16.06	90.23±2.93	62.47±4.71	1.19±0.068
NS-m prior	105.00±42.34	8.44±2.11	80.10±13.62	90.82±5.61	63.41±9.38	1.21±0.096
after	185.60±33.83e	59.58±5.96	142.90±19.93e	67.76±3.22f	38.44±2.46f	1.10±0.058
NS-MI prior	98.98±5.59	10.38±0.82	72.00±9.38	89.52±1.68	61.05±2.28	1.22±0.059
after	440.30±51.03f	322.50±28.04f	315.20±60.45f	13.29±4.67f	26.97±8.93f	0.91±0.027f
RGE-b prior	108.50±28.67	13.25±1.05	74.14±7.59	87.52±1.58	57.49±2.46	1.14±0.045
after	119.30±10.59	22.56±3.22	65.45±8.55	81.12±5.82	50.38±5.72	1.18±0.056
RGE-m prior	94.63±17.94	11.62±2.61	67.66±7.48	87.99±5.19	58.67±7.46	1.16±0.071
after	109.80±5.50	29.36±2.54	115.10±31.00	73.32±2.95f	42.44±2.60e	1.16±0.048
RGE-MI prior	112.20±15.71	19.09±1.50	65.54±8.96	83.03±0.89	52.02±0.93	1.15±0.038
after	367.00±84.96f	234.30±38.74f	307.80±54.53f	19.01±6.86f	37.09±11.63e	0.81±0.147f